Medtronic & #039;s Tiny Pain Treatment Device Approved in Europe

Medtronic has seen its pain stimulation sales slip in recent quarters, but that could be about to change.  The company just received a CE mark for its Intellis platform for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in the management of certain types of chronic pain. This clearance to sell Intellis in Europe follows FDA approval of the Intellis SCS in September. The platform has a lot going for it, including its size. According to Medtronic, this is the world's smallest fully implantable SCS neurostimulator. The device is designed to simplify and improve the patient experience with improved battery performance that can power Medtronic's recently launched Evolve workflow. The Intellis platform is managed on the Samsung Galaxy Tab S2 tablet interface and can record and track patient activity around the clock, the company said. "Pain stimulation has been declining in the mid single-digits, even a little higher over the last couple of quarters," said Geoff Martha, president of Medtronic's restorative therapies group, during the company's earnings call in August. Not only is Intellis the smallest of its kind on the market, Martha said it's 40% smaller than Medtronic's current implantable rechargeable system. It will also recharge about 75% faster than the current device, he said. The battery can be fully recharged, from empty to full, in about an hour, the company said. "And you combine that with our Evolve workflow that we launched a few ...
Source: MDDI - Category: Medical Devices Authors: Tags: Implants Source Type: news